Atlas Trials

REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis

Clinical trial NCT06955416 · RECRUITING

Trial details

NCT number
NCT06955416
Sponsor
POLYSAN Scientific & Technological Pharmaceutical Company
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Diabetic Ketoacidosis
Start date
2025-05-01
Primary completion
2027-12-01
Enrollment
312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.